Jefferies Initiates Coverage On PetMed Express with Hold Rating, Announces Price Target of $28
Jefferies analyst Stephanie Wissink initiates coverage on PetMed Express (NASDAQ:PETS) with a Hold rating and announces Price Target of $28.
Understanding PetMed Express’s Unusual Options Activity
On Monday, shares of PetMed Express (NASDAQ:PETS) saw unusual options activity. After the option alert, the stock price moved up to $27.8.
PetMed Stock Falls As Q1 Earnings Trail Analyst Consensus, Operating Margin Contraction
PetMed Express Inc (NASDAQ:PETS) has reported a Q1 EPS of $0.22, lagging the consensus of 0.36 and lower than $0.39 posted…
PetMed Express Q1 EPS $0.22 Misses $0.36 Estimate, Sales $79.30M Miss $86.58M Estimate
PetMed Express (NASDAQ:PETS) reported quarterly earnings of $0.22 per share which missed the analyst consensus estimate of $0.36 by 38.89 percent. This is a 43.59 percent decrease over earnings of $0.39 per share from
Earnings Scheduled For July 26, 2021
Companies Reporting Before The Bell
• Otis Worldwide (NYSE:OTIS) is estimated to report quarterly earnings at $0.71 per share on revenue of $3.45 billion.
Stocks That Hit 52-Week Lows On Friday
Before 10 a.m. ET Friday, 117 stocks made new 52-week lows.
Earnings Preview For PetMed Express
On Monday, July 26, PetMed Express (NASDAQ:PETS) will release its latest earnings report. Decipher the announcement with Benzinga's help.
Unusual Options Activity Insight: PetMed Express
PetMed Express (NASDAQ:PETS) shares experienced unusual options activity on Wednesday. The stock price moved down to $29.18 following the option alert.
PetMed Express Says On June 11 Co’s President And CEO Entered Into A CEO Separation Agreement
On June 11, 2021, PetMed Express, Inc. (the “Company”) and Menderes Akdag, the Company’s President and Chief Executive Officer, entered into a CEO Separation Agreement and General Release setting forth